John Wagstaff
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 90
- Cancer Immunotherapy and Biomarkers 32
- CAR-T cell therapy research 17
-
- Cancer Genomics and Diagnostics 17
- Co-authors
- Cezary SzczylikRobert E. HawkinsLauren McCannIan D. DavisCora N. SternbergOleg GladkovEunsik LeeCarlos H. Barrios
- Journals
- Annals of Oncology (19 papers)Journal of Clinical Oncology (16 papers)European Journal of Cancer (12 papers)British Journal of Cancer (12 papers)Cancer Immunology Immunotherapy (5 papers)
- Partner nations
- United KingdomNetherlandsUnited States
In The Last Decade
John Wagstaff
203 papers receiving 10.2k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Oncology 4.4k
- Cancer Research 2.0k
- Pulmonary and Respiratory Medicine 3.5k
- Immunology 2.1k
- Molecular Biology 4.5k
Countries citing papers authored by John Wagstaff
This map shows the geographic impact of John Wagstaff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Wagstaff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Wagstaff more than expected).
Fields of papers citing papers by John Wagstaff
This network shows the impact of papers produced by John Wagstaff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Wagstaff. The network helps show where John Wagstaff may publish in the future.
Co-authors
The 25 scholars most cited alongside John Wagstaff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 0 | |
| 3 | 2020 | 7 | |
| 4 | 2015 | 33 | |
| 5 | 2013 | 19 | |
| 6 | Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial Hit paper breakdown → | 2010 | 1940 |
| 7 | 2009 | 9 | |
| 8 | 2009 | 6 | |
| 9 | 2004 | 1 | |
| 10 | 2004 | 35 | |
| 11 | neurophysiogical behaviour of Purkinje cells in mice with inactivated maternally inherited ube3a gene | 2003 | 2 |
| 12 | PIP(2) binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome | 2003 | 1 |
| 13 | 2000 | 49 | |
| 14 | 1997 | 54 | |
| 15 | Effect of suramin on adenylate cyclase and protein kinase C. | 1994 | 9 |
| 16 | 1994 | 11 | |
| 17 | 1992 | 8 | |
| 18 | Localization of the gene encoding the GABAA receptor beta 3 subunit to the Angelman/Prader-Willi region of human chromosome 15. | 1991 | 155 |
| 19 | 1985 | 2 | |
| 20 | 1982 | 6 |
About John Wagstaff
John Wagstaff is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Genetics and Immunology and Allergy, having authored 206 papers that have together received 10.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (32 papers), Renal cell carcinoma treatment (25 papers), Cancer Genomics and Diagnostics (17 papers), Lymphoma Diagnosis and Treatment (17 papers), CAR-T cell therapy research (17 papers), Immunotherapy and Immune Responses (15 papers), Renal and related cancers (15 papers) and Genetic Syndromes and Imprinting (14 papers). The work is most often cited by research in Oncology (4.4k citations), Cancer Research (2.0k citations), Pulmonary and Respiratory Medicine (3.5k citations), Immunology (2.1k citations) and Molecular Biology (4.5k citations). John Wagstaff has collaborated with scholars based in United Kingdom, Netherlands and United States. Frequent co-authors include Cezary Szczylik, Robert E. Hawkins, Lauren McCann, Ian D. Davis, Cora N. Sternberg, Oleg Gladkov, Eunsik Lee, Carlos H. Barrios, Pamela Salman and Jozef Mardiak. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, European Journal of Cancer, British Journal of Cancer and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.